TAKE Share Price Today | Stock Price & TAKE Share Screener
As of October 5, 2026, the live TAKE share price (NSE: TAKE) is ₹12.06 on NSE and ₹12.07 on BSE, down 4.66% from the previous close, with shares trading between ₹12.02 and ₹12.90 in today's trading session, and a 52-week range of ₹12.06–₹23.76. Check TAKE 52-week for the annual price range and momentum. Use the TAKE stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today TAKE opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Key Statistics and Valuation Ratios
Over the trailing twelve months the company reported revenue of ₹59 and net income of ₹4, with EBITDA of ₹4, an operating margin of -2.0% and a profit margin of 6.8%.
TAKE Share Price Chart
Track the current stock price of TAKE with an interactive chart. Analyse TAKE share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete TAKE stock quote in one place.
The quote of ₹12.06 sits between the 52-week low of ₹12.06 and the 52-week high of ₹23.76, and the latest session moved -4.66% from the previous close.
TAKE Company Profile - Fundamental Screener
Screen TAKE company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for TAKE shares across the equity market and its stock price history, plus the wider market trend.
The company is classified under the Healthcare sector and the Healthcare Technology industry, and it trades under ISIN INE142I01023.
Company Details
Classification
Identifiers and Leadership
TAKE Balance Sheet Screener
Screen TAKE balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.
For 2026, total assets were ₹36, down from ₹37 in 2025.
Latest statistics put total assets at ₹36 and shareholder funds at ₹31.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
Assets |
||||||||||
| Total Assets | 36 | 37 | 88 | 224 | 1,223 | 1,845 | 2,483 | 2,334 | 1,844 | 1,373 |
| Current Assets | 24 | 24 | 35 | 90 | 1,086 | 861 | 1,199 | 1,172 | 1,178 | 779 |
| Fixed Assets | 0 | 0 | 30 | 73 | 101 | 934 | 1,234 | 1,091 | 589 | 554 |
Liabilities |
||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 0 | 0 | 8 | 15 | 36 | 196 | 238 | 83 | 92 | 84 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Shareholders' Equity |
||||||||||
| Total Equity | 31 | 21 | -9 | 109 | 181 | 1,124 | 1,585 | 1,527 | 1,337 | 953 |
| Share Capital | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 13 |
| Reserves & Surplus | 16 | 6 | -24 | 94 | 166 | 1,110 | 1,561 | 1,504 | 1,314 | 898 |
TAKE Income Statement Screener - Profit & Revenue Analysis
Screen TAKE income statement and profit fundamentals. Analyze TAKE quarterly results. TAKE reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.
For 2026-Mar, revenue was ₹59 and net profit was ₹4, equal to earnings per unit of ₹0.29, at an operating margin of -2%.
In that period expenses were ₹55, interest cost ₹0 and tax ₹0. The next period listed, 2026-Jun, shows revenue of ₹32 and net profit of ₹1.
| Item | 2026-Mar | 2026-Jun | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar | 2023-Jun | 2023-Sept | 2023-Dec | 2022-Mar |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and Expenses | |||||||||||||||
| Revenue | 59 | 32 | 2 | 0 | 7 | 2 | 0 | 0 | 0 | 51 | 36 | 4 | 1 | 4 | 44 |
| Expenses | 55 | 31 | 6 | 1 | 0 | 0 | 110 | 3 | 1 | 3 | 84 | 8 | 2 | 2 | 762 |
Operating Costs and Margins | |||||||||||||||
| EBITDA | 4 | 1 | -5 | -1 | 7 | 1 | -110 | -3 | -1 | 48 | -48 | -4 | -1 | 2 | -718 |
| Operating Profit % | -2.00% | -1.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -123.00% | -118.00% | -2900.00% | 0.00% | -1761.00% |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4 | 0 | 0 | 0 | 5 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 4 | 1 | 1 | 1 | 2 |
Profit and Earnings | |||||||||||||||
| Profit Before Tax | 4 | 1 | -5 | -1 | 6 | 1 | -110 | -4 | -2 | 48 | -56 | -5 | -2 | 1 | -725 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 4 | 0 |
| Net Profit | 4 | 1 | -5 | -1 | 6 | 1 | -111 | -4 | -2 | 48 | -56 | -5 | -2 | -2 | -725 |
| EPS | 0.29 | 0.07 | -0.33 | -0.06 | 0.43 | 0.07 | -7.56 | -0.26 | -0.11 | 3.26 | -3.83 | -0.36 | -0.11 | -0.15 | -49.81 |
TAKE Cash Flow Screener - Liquidity Fundamentals
Screen TAKE cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.
In 2026-March, operating activities used ₹4, and net cash flow was an outflow of ₹3.
Over the same period, investing activities provided ₹2 and financing activities used ₹1.
| Item | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March |
|---|---|---|---|---|---|---|---|---|---|---|
Cash from Operations and Investing | ||||||||||
| Operating Activities | -4 | -16 | 9 | 20 | 30 | 135 | 211 | 104 | 121 | 56 |
| Investing Activities | 2 | 22 | -8 | -3 | 15 | -58 | -233 | -474 | -179 | -130 |
Financing and Net Cash | ||||||||||
| Financing Activities | -1 | -3 | -12 | -36 | -55 | -84 | 21 | 100 | 302 | 56 |
| Net Cash Flow | -3 | 3 | -10 | -18 | -10 | -6 | -2 | -270 | 243 | -18 |
TAKE Shareholding Pattern Screener
See TAKE shareholding pattern with promoter, FII, and DII holdings. Check TAKE promoter holding and ownership changes for TAKE on TickJournal, and see how institutional stock price moves affect the market.
In 2026-Jun, promoters held 0.00%, foreign institutions 0.21%, domestic institutions 0.00% and the public 29.63%, spread across 63,213 shareholders.
The shareholder count was 63,213 in 2026-Jun, compared with 64,699 in 2026-Mar.
| Item | 2026-Jun | 2026-Mar | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept |
|---|---|---|---|---|---|---|---|---|
Promoter Holding | ||||||||
| Promoter Holding | 0.00% | 0.00% | 0.00% | 5.19% | 53.34% | 53.41% | 53.41% | 53.41% |
Institutional Investors | ||||||||
| FII Holding | 0.21% | 0.29% | 0.56% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.01% | 0.00% | 0.00% |
Government, Public and Others | ||||||||
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 29.63% | 31.59% | 38.80% | 40.40% | 40.49% | 40.45% | 40.15% | 39.78% |
| Other Holding | 70.17% | 68.12% | 60.64% | 54.41% | 6.17% | 6.14% | 6.44% | 6.81% |
| Shareholder Count | 63,213 | 64,699 | 70,324 | 74,410 | 75,141 | 75,988 | 77,163 | 78,033 |
Dividend Yield Screener - Share Price & Share Analysis
Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by TAKE. TAKE dividend yield can be compared with peers and other stocks in the market.
The latest dividend recorded was ₹0.00 per unit for 2026-March, a yield of 0.00%, compared with ₹0.00 for 2025-March.
Dividends are listed for 10 periods, with the three most recent payouts at ₹0.00, ₹0.00 and ₹0.00 per unit.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹0.00 | 0.00% |
| 2024-March | ₹0.00 | 0.00% |
| 2023-March | ₹0.00 | 0.00% |
| 2022-March | ₹0.00 | 0.00% |
| 2021-March | ₹0.00 | 0.00% |
| 2020-March | ₹0.00 | 0.00% |
| 2019-March | ₹1.00 | 2.52% |
| 2018-March | ₹1.60 | 1.07% |
| 2017-March | ₹1.00 | 0.61% |
TAKE Stock Index Membership - Nifty & Sensex
See which indices include TAKE stock. Check TAKE index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.
Complete Index List
TAKE Market Events Screener - Corporate Actions
Get TAKE corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check TAKE stock events that may affect TAKE share price, along with derivatives, futures and options activity and sector gainers.
15 corporate actions are listed, the most recent entry being Annual General Meeting dated September 29, 2026, with a record date of September 29, 2026.
It is followed by Quarterly Result Announcement dated August 11, 2026 and Quarterly Result Announcement dated May 20, 2026.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-09-29 | 2026-09-29 | Annual General Meeting | NA | 10.67% |
| 2026-08-11 | 2026-08-11 | Quarterly Result Announcement | NA | 2.86% |
| 2026-05-20 | 2026-05-20 | Quarterly Result Announcement | NA | -0.27% |
| 2026-05-13 | 2026-05-13 | Change Of Name | NA | 0.00% |
| 2026-03-07 | 2026-03-07 | Extraordinary General Meeting | NA | -26.51% |
| 2026-02-14 | 2026-02-14 | Quarterly Result Announcement | NA | 17.42% |
| 2025-10-27 | 2025-10-27 | Quarterly Result Announcement | NA | 10.22% |
| 2025-09-30 | 2025-09-30 | Annual General Meeting | NA | 1.30% |
| 2025-07-30 | 2025-07-30 | Extraordinary General Meeting | NA | -7.62% |
| 2025-07-07 | 2025-07-07 | Quarterly Result Announcement | NA | 15.62% |
| 2025-05-30 | 2025-05-30 | Quarterly Result Announcement | NA | -8.04% |
| 2025-02-12 | 2025-02-12 | Quarterly Result Announcement | NA | -8.58% |
| 2025-01-22 | 2025-01-22 | Quarterly Result Announcement | NA | -3.01% |
| 2024-10-09 | 2024-10-09 | Extraordinary General Meeting | NA | 6.32% |
| 2024-08-14 | 2024-08-14 | Annual General Meeting | NA | -7.08% |
TAKE Competitors Screener - Peer Stocks Comparison
Screen TAKE competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.
The comparison table covers 9 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Syngene International | 15,178 | 69.14 | 3,809 | 2.56% | 317 | 39.42 |
| Indegene | 14,778 | 36.63 | 3,583 | 21.58% | 401 | 65.95 |
| Suven Life Sciences | 9,089 | -26.86 | 21 | 19.32% | -276 | 38.29 |
| Vimta Labs | 2,615 | 35.09 | 322 | 0.22% | 41 | 37.53 |
| Bilcare | 232 | -38.52 | 764 | -5.33% | -17 | 55.07 |
| TAKE | 218 | 17.77 | 61 | 497.06% | 4 | 35.50 |
| Jeevan Scientific Technology | 154 | 31.28 | 62 | 29.56% | 2 | 46.75 |
| Adeshwar Meditex | 24 | 33.09 | 56 | -33.21% | 1 | 52.35 |
| Vanta Bioscience | 15 | 130.40 | 2 | -13.33% | 0 | 44.45 |
TAKE Company Announcements - News & Reports Screener
Screen TAKE latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.
20 recent announcements are listed, the latest dated October 3, 2026.
The next most recent announcements are dated September 12, 2026 and September 9, 2026.
| Date | Update | Actions |
|---|---|---|
| 2026-10-03 | Closure of Trading Window | - |
| 2026-09-12 | Intimation Of Cut-Off Date For E-Voting For The 25Th Annual General Meeting | - |
| 2026-09-09 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-09-07 | Reg. 34 (1) Annual Report. | - |
| 2026-09-07 | Notice Of The 25Th Annual General Meeting For FY 2025-26 On Tuesday September 29 2026 At 12:00 P.M. | - |
| 2026-09-05 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-09-03 | Board Meeting Outcome for Outcome Of Board Meeting Held On Thursday September 3 2026 | - |
| 2026-09-01 | Board Meeting Outcome for Outcome Of Board Meeting Held On Tuesday September 1 2026 | - |
| 2026-08-17 | Shareholder Meeting / Postal Ballot-Scrutinizer"s Report | - |
| 2026-08-13 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-08-11 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-08-11 | Board Meeting Outcome for Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter Ended June 30 2026 | - |
| 2026-08-11 | Unaudited Standalone And Consolidated Financial Results For The Quarter Ended June 30 2026. | - |
| 2026-08-04 | Board Meeting Intimation for Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter Ended June 30 2026. | - |
| 2026-07-15 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-07-15 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-07-13 | Shareholder Meeting / Postal Ballot-Notice of Postal Ballot | - |
| 2026-07-09 | Board Meeting Outcome for Outcome Of The Board Meeting Held On Thursday July 09 2026 | - |
| 2026-06-26 | Announcement under Regulation 30 (LODR)-Change of Company Name | - |
| 2026-06-25 | Closure of Trading Window | - |
Frequently Asked Questions
How is the company valued right now?
The current quote is ₹12.06, within a 52-week range of ₹12.06 to ₹23.76. The P/E ratio is 17.77 and the P/B ratio is 7.38, with earnings per unit of ₹0.74. Market capitalisation stands at ₹218.05 Cr. The company operates in the Healthcare sector, in the Healthcare Technology industry, so compare these ratios with its sector peers in the table above.
About This Data
Quotes are sourced from the NSE and the BSE. Key statistics were last updated on October 6, 2026. This page covers 10 balance sheet periods, 15 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.